相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity
Seraina Faes et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass
Mee-Sup Yoon
FRONTIERS IN PHYSIOLOGY (2017)
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Yiqun Zhang et al.
CANCER CELL (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes
Song Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
Kate T. Murphy
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia can findings from animal models be translated to humans?
Tara C. Mueller et al.
BMC CANCER (2016)
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Michele Petruzzelli et al.
GENES & DEVELOPMENT (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
An evolutionarily conserved pathway controls proteasome homeostasis
Adrien Rousseau et al.
NATURE (2016)
TORC2 Structure and Function
Christl Gaubitz et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
White Adipose Tissue Browning: A Double-edged Sword
Abdikarim Abdullahi et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling
Xiangzheng Chen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
Shinji Hatakeyama et al.
SKELETAL MUSCLE (2016)
Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer
Eva Pigna et al.
SCIENTIFIC REPORTS (2016)
Muscle wasting associated with the long-term use of mTOR inhibitors
Bishal Gyawali et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
The Roles of mTOR Complexes in Lipid Metabolism
Alexandre Caron et al.
ANNUAL REVIEW OF NUTRITION, VOL 35 (2015)
PI3K and AKT: Unfaithful Partners in Cancer
Seraina Faes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy
Jinghui Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
Pengda Liu et al.
CANCER DISCOVERY (2015)
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
Nathan A. Stephens et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
Michele Petruzzelli et al.
CELL METABOLISM (2014)
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure
Jochen Springer et al.
EUROPEAN HEART JOURNAL (2014)
Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia
Melissa J. Puppa et al.
FASEB JOURNAL (2014)
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
Serkan Kir et al.
NATURE (2014)
Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation
Maria Tsoli et al.
PLOS ONE (2014)
Evidence and Mechanisms of Fat Depletion in Cancer
Maryam Ebadi et al.
NUTRIENTS (2014)
Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia
Fabio Penna et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK
James P. White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Sustained Activation of mTORC1 in Skeletal Muscle Inhibits Constitutive and Starvation-Induced Autophagy and Causes a Severe, Late-Onset Myopathy
Perrine Castets et al.
CELL METABOLISM (2013)
Mechanisms regulating skeletal muscle growth and atrophy
Stefano Schiaffino et al.
FEBS JOURNAL (2013)
Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse
Nandini D. P. K. Manne et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia
Liuping Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
Venus Thomanetz et al.
JOURNAL OF CELL BIOLOGY (2013)
Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome
Brittany L. Jacobs et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue
Maria J. Pereira et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
mTOR kinase structure, mechanism and regulation
Haijuan Yang et al.
NATURE (2013)
Understanding the mechanisms and treatment options in cancer cachexia
Kenneth Fearon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
Issam Ben-Sahra et al.
SCIENCE (2013)
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Aaron M. Robitaille et al.
SCIENCE (2013)
BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte Differentiation
Yixin Yao et al.
SCIENCE SIGNALING (2013)
Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival
Francis Robert et al.
CANCER RESEARCH (2012)
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Asami Hagiwara et al.
CELL METABOLISM (2012)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Connecting mTORC1 signaling to SREBP-1 activation
Inan Bakan et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2
Minsheng Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia
M. L. Batista et al.
JOURNAL OF ENDOCRINOLOGY (2012)
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Christian C. Dibble et al.
MOLECULAR CELL (2012)
Low Levels of Lipogenic Enzymes in Peritumoral Adipose Tissue of Colorectal Cancer Patients
Maria Notarnicola et al.
LIPIDS (2012)
Pre-cachexia in patients with stages I-III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system
C. M. Op den Kamp et al.
LUNG CANCER (2012)
PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12
Xiaoqing Gan et al.
NATURE CELL BIOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Dudley W. Lamming et al.
SCIENCE (2012)
The effect of exercise on IL-6-induced cachexia in the ApcMin/+ mouse
Melissa J. Puppa et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner
Pippa F. Cosper et al.
CANCER RESEARCH (2011)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies et al.
CELL METABOLISM (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse
James P. White et al.
PLOS ONE (2011)
Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
Yonghao Yu et al.
SCIENCE (2011)
The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
Peggy P. Hsu et al.
SCIENCE (2011)
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Suman K. Das et al.
SCIENCE (2011)
Adipose tissue pathways involved in weight loss of cancer cachexia
I. Dahlman et al.
BRITISH JOURNAL OF CANCER (2010)
Role of β1-adrenoceptor in increased lipolysis in cancer cachexia
Dong-xing Cao et al.
CANCER SCIENCE (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients
R. A. Murphy et al.
CLINICAL NUTRITION (2010)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
Anil Kumar et al.
DIABETES (2010)
Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
Partha Chakrabarti et al.
DIABETES (2010)
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Vanessa P. Houde et al.
DIABETES (2010)
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
Fabio Penna et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Valerie Risson et al.
JOURNAL OF CELL BIOLOGY (2009)
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rapamycin Protects Against High Fat Diet-Induced Obesity in C57BL/6J Mice
Geng-Ruei Chang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
Hui H. Zhang et al.
PLOS ONE (2009)
mTOR complex 2 in adipose tissue negatively controls whole-body growth
Nadine Cybulski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Interleukin-6 and cachexia in ApcMin/+ mice
Kristen A. Baltgalvis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Thomas Porstmann et al.
CELL METABOLISM (2008)
Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Pazit Polak et al.
CELL METABOLISM (2008)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Computational modeling of cancer cachexia
Kevin D. Hall et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2008)
Cachexia worsens prognosis in patients with resectable pancreatic cancer
Jeannine Bachmann et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy
Espen E. Spangenburg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
Role of the PI3-kinase/m Tor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liver
Daniel Mauvoisin et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2007)
Identification of Protor as a novel Rictor-binding component of mTOR complex-2
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2007)
Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia
Thomas L. Schmitt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Mechanism of increased lipolysis in cancer cachexia
Thorhallur Agustsson et al.
CANCER RESEARCH (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation
Helen L. Eley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
C. Bing et al.
BRITISH JOURNAL OF CANCER (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s
Maria A. Frias et al.
CURRENT BIOLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
MK Holz et al.
CELL (2005)
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
J Khal et al.
BRITISH JOURNAL OF CANCER (2005)
Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care -: Correlations with food intake, metabolism, exercise capacity, and hormones
M Fouladiun et al.
CANCER (2005)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
M Ohanna et al.
NATURE CELL BIOLOGY (2005)
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase
PP Roux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients
JD Morrisett et al.
TRANSPLANTATION PROCEEDINGS (2003)
GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR
DH Kim et al.
MOLECULAR CELL (2003)
The forkhead transcription factor Foxo1 regulates adipocyte differentiation
J Nakae et al.
DEVELOPMENTAL CELL (2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification
G Pallafacchina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
C Rommel et al.
NATURE CELL BIOLOGY (2001)
Increased muscle ubiquitin mRNA levels in gastric cancer patients
M Bossola et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
分享论文
